| Value | ₹0.82 Cr |
|---|
BSE filing, NSE: FEDERALBNK. Summary written from the filing by ALFA Finder's alert engine.
Federal Bank Ltd: key numbers
- Share price
- ₹346.00
- Market cap
- ₹85,562 Cr
- Revenue (annual)
- ₹29,674 Cr
- Net profit (annual)
- ₹4,345 Cr
- P/E (TTM)
- 16.5×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 28.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Federal Bank Ltd
All →Federal Bank Employee Stock Options
Federal Bank allotted 111,880 equity shares of Rs.2 face value on exercise of employee stock options under ESOS 2010, ESOS 2017 and ESIS 2023. No cash consideration value is stated in the filing.
Federal Bank Price Movement Clarification
Federal Bank clarified to NSE that it is not in active acquisition talks and has no material undisclosed information. The Bank stated there is no material impact on the company from the news item.
Federal Bank Earnings Call Transcript: Key Takeaways
Federal Bank reported record profits driven by strong CASA growth and fee income despite margin pressure.
Federal Bank Results Update
Federal Bank reported a record net profit of ₹1,386.09 crore for Q2 FY27, up 45.10% YoY. Total business crossed ₹6 lakh crore with gross advances exceeding ₹3 lakh crore.
- Value
- ₹1,386 Cr
- new branches
- 12.0 branches
Federal Bank Investor Presentation: Key Takeaways
Federal Bank reported record quarterly net profit of ₹1,386 Cr for Q2 FY27, driven by 20% YoY growth in business franchise and total assets crossing ₹3 Lakh Cr.
Federal Bank Other Announcement
The Federal Bank Limited filed its security cover certificate for the quarter ended September 2026. All outstanding non-convertible debentures totaling Rs. 3,195 Crore are unsecured.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.